LOVE TED W
Insider CIK 1188919 · ONXX EVP, R&D and Tech. Operations · SGEN Director · AFFY Director · ANX Director · SNTS Director · FOLD Director · JAZZ Director · PTLA Director · KBIO Director · ONTY Director · GBT See Remarks., Director · RPRX Director · GPCR Director · GILD Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2026-08-31 | 2026-09-02 | 737 | $241.39 | $177.9K | 2,389 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2026-08-31 | 2026-09-02 | 6 | $244.06 | $1.5K | 3,126 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2026-08-31 | 2026-09-02 | 737 | $241.39 | $177.9K | 2,389 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2026-08-31 | 2026-09-02 | 6 | $244.06 | $1.5K | 3,126 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2026-08-05 | 2026-08-07 | 1,605 | — | $0 | 3,132 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2026-08-05 | 2026-08-07 | 1,605 | — | $0 | 3,132 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award deriv | 2026-06-17 | 2026-06-18 | 39,453 | — | $0 | 39,453 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2026-06-05 | 2026-06-08 | 4,545 | — | $0 | 58,393 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | A Award deriv | 2026-04-30 | 2026-05-04 | 4,884 | — | $0 | 4,884 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | A Award | 2026-04-30 | 2026-05-04 | 1,146 | — | $0 | 5,484 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2026-02-26 | 2026-03-02 | 1,527 | — | $0 | 1,527 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award deriv | 2025-06-23 | 2025-06-25 | 51,804 | — | $0 | 51,804 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2025-05-13 | 2025-05-14 | 7,614 | — | $0 | 53,848 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | A Award deriv | 2025-05-07 | 2025-05-08 | 6,809 | — | $0 | 6,809 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | A Award | 2025-05-07 | 2025-05-08 | 1,516 | — | $0 | 4,338 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award deriv | 2024-06-25 | 2024-06-27 | 33,595 | — | $0 | 33,595 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2024-06-07 | 2024-06-10 | 9,293 | — | $0 | 46,234 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | A Award deriv | 2024-05-08 | 2024-05-09 | 12,648 | — | $0 | 12,648 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | A Award | 2024-05-08 | 2024-05-09 | 2,310 | — | $0 | 2,822 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | A Award deriv | 2024-02-02 | 2024-02-06 | 2,996 | — | $0 | 2,996 | SEC↗ |
| GILD GILEAD SCIENCES, INC. | A Award | 2024-02-02 | 2024-02-06 | 512 | — | $0 | 512 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 449 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 2,044 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 4,460 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 3,676 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 3,462 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer | 2023-12-14 | 2023-12-15 | 4,255 | $229.00 | $974.4K | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award deriv | 2023-08-03 | 2023-08-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2023-06-23 | 2023-06-26 | 7,747 | — | $0 | 36,941 | SEC↗ |
| SGEN Seagen Inc. | A Award | 2023-05-31 | 2023-06-02 | 2,044 | — | $0 | 6,748 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 11,250 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 114,190 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 132,433 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 118,090 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 26,865 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 47,223 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 63,768 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 109,116 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 141,400 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 114,515 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 122,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 145,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer | 2022-10-05 | 2022-10-06 | 119,650 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer | 2022-10-05 | 2022-10-06 | 102,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer | 2022-10-05 | 2022-10-06 | 576,318 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer | 2022-10-05 | 2022-10-06 | 119,650 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer | 2022-10-05 | 2022-10-06 | 2,500 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer | 2022-10-05 | 2022-10-06 | 2,500 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-09-27 | 2022-09-29 | 18,291 | — | $0 | 114,515 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-09-27 | 2022-09-29 | 18,291 | $16.40 | $300.0K | 576,318 | SEC↗ |
| GBT Global Blood Therapeutics, | G Gift | 2022-09-13 | 2022-09-29 | 17,650 | — | $0 | 119,650 | SEC↗ |
| GBT Global Blood Therapeutics, | G Gift | 2022-09-13 | 2022-09-29 | 35,300 | — | $0 | 558,027 | SEC↗ |
| GBT Global Blood Therapeutics, | G Gift | 2022-09-13 | 2022-09-29 | 17,650 | — | $0 | 119,650 | SEC↗ |
| GBT Global Blood Therapeutics, | G Gift | 2022-09-09 | 2022-09-29 | 221,200 | — | $0 | 593,327 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-09-01 | 2022-09-06 | 9,444 | — | $0 | 47,223 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-09-01 | 2022-09-06 | 9,109 | — | $0 | 63,768 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2022-09-01 | 2022-09-06 | 9,200 | $68.15 | $627.0K | 814,527 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-09-01 | 2022-09-06 | 9,444 | — | $0 | 814,618 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-09-01 | 2022-09-06 | 9,109 | — | $0 | 823,727 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-08-01 | 2022-08-03 | 11,250 | — | $0 | 11,250 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-08-01 | 2022-08-03 | 8,955 | — | $0 | 26,865 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2022-08-01 | 2022-08-03 | 10,018 | $32.40 | $324.6K | 805,174 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-08-01 | 2022-08-03 | 20,205 | — | $0 | 815,192 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2022-06-24 | 2022-06-24 | 6,328 | — | $0 | 29,194 | SEC↗ |
| SGEN Seagen Inc. | A Award deriv | 2022-05-13 | 2022-05-17 | 3,676 | — | $0 | 3,676 | SEC↗ |
| SGEN Seagen Inc. | A Award | 2022-05-13 | 2022-05-17 | 1,503 | — | $0 | 4,704 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2022-03-01 | 2022-03-03 | 72,877 | — | $0 | 72,877 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2022-03-01 | 2022-03-03 | 118,090 | — | $0 | 118,090 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2022-03-01 | 2022-03-03 | 72,877 | — | $0 | 72,877 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-03-01 | 2022-03-03 | 9,445 | — | $0 | 56,667 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-03-01 | 2022-03-03 | 9,445 | — | $0 | 799,061 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2022-03-01 | 2022-03-03 | 4,074 | $29.87 | $121.7K | 794,987 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2022-02-28 | 2022-03-03 | 839 | $25.37 | $21.3K | 789,616 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-02-01 | 2022-02-03 | 8,955 | — | $0 | 35,820 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-02-01 | 2022-02-03 | 11,250 | — | $0 | 22,500 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-02-01 | 2022-02-03 | 9,750 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-02-01 | 2022-02-03 | 29,955 | — | $0 | 799,308 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2022-02-01 | 2022-02-03 | 10,531 | $29.33 | $308.9K | 788,777 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-09-01 | 2021-09-03 | 9,444 | — | $0 | 66,112 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2021-09-01 | 2021-09-03 | 4,683 | $29.85 | $139.8K | 794,174 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2021-09-01 | 2021-09-03 | 9,444 | — | $0 | 798,857 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-08-03 | 11,250 | — | $0 | 33,750 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-08-03 | 8,955 | — | $0 | 44,775 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-08-03 | 9,750 | — | $0 | 9,750 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-09-24 | 9,750 | — | $0 | 9,750 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-09-24 | 11,250 | — | $0 | 33,750 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-08-01 | 2021-09-24 | 8,955 | — | $0 | 44,775 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2021-08-01 | 2021-08-03 | 14,853 | $27.33 | $405.9K | 789,413 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2021-08-01 | 2021-08-03 | 29,955 | — | $0 | 804,266 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2021-08-01 | 2021-09-24 | 14,853 | $27.33 | $405.9K | 789,413 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2021-08-01 | 2021-09-24 | 29,955 | — | $0 | 804,266 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2021-06-25 | 2021-06-29 | 5,726 | — | $0 | 22,866 | SEC↗ |
| SGEN Seagen Inc. | A Award deriv | 2021-05-14 | 2021-05-18 | 3,462 | — | $0 | 3,462 | SEC↗ |
| SGEN Seagen Inc. | A Award | 2021-05-14 | 2021-05-18 | 1,402 | — | $0 | 3,201 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2021-03-01 | 2021-03-03 | 132,433 | — | $0 | 132,433 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2021-03-01 | 2021-03-03 | 75,556 | — | $0 | 75,556 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2021-02-28 | 2021-03-03 | 370 | $36.21 | $13.4K | 774,311 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-02-01 | 2021-02-03 | 8,955 | — | $0 | 53,730 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-02-01 | 2021-02-03 | 9,750 | — | $0 | 19,500 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-02-01 | 2021-02-03 | 12,063 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-02-01 | 2021-02-03 | 11,250 | — | $0 | 45,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2021-02-01 | 2021-02-03 | 42,018 | — | $0 | 791,834 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2021-02-01 | 2021-02-03 | 17,893 | $49.49 | $885.5K | 773,941 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2020-08-17 | 2020-08-18 | 4,460 | — | $0 | 4,460 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2020-08-17 | 2020-08-18 | 1,799 | — | $0 | 1,799 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2020-08-13 | 2020-08-17 | 7,280 | — | $0 | 17,280 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-08-01 | 2020-08-04 | 8,955 | — | $0 | 62,685 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-08-01 | 2020-08-04 | 11,250 | — | $0 | 56,250 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-08-01 | 2020-08-04 | 9,750 | — | $0 | 29,250 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-08-01 | 2020-08-04 | 12,062 | — | $0 | 12,063 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2020-08-01 | 2020-08-04 | 42,017 | — | $0 | 770,650 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2020-08-01 | 2020-08-04 | 20,834 | $67.48 | $1.41M | 749,816 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 14,812 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 11,377 | $0.06 | $683 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer | 2020-07-02 | 2020-07-02 | 15,575 | $18.00 | $280.4K | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | G Gift | 2020-06-12 | 2020-08-04 | 306,000 | — | $0 | 728,633 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2020-06-12 | 2020-06-15 | 11,377 | — | $0 | 11,377 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2020-06-12 | 2020-06-15 | 7,281 | — | $0 | 15,575 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2020-06-04 | 2020-06-08 | 18,574 | — | $0 | 18,574 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2020-06-04 | 2020-06-08 | 5,855 | — | $0 | 131,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-06-01 | 2020-06-03 | 141,400 | — | $0 | 141,400 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-04-28 | 2020-04-29 | 40,000 | $80.00 | $3.20M | 1,034,633 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-04-27 | 2020-04-29 | 1,517 | $80.63 | $122.3K | 1,074,633 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-04-27 | 2020-04-29 | 1,300 | $81.15 | $105.5K | 1,076,150 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-02-18 | 2020-02-20 | 1,818 | $70.92 | $128.9K | 1,077,450 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-02-18 | 2020-02-20 | 2,189 | $70.22 | $153.7K | 1,079,268 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-02-03 | 2020-02-04 | 114,190 | — | $0 | 114,190 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-02-03 | 2020-02-04 | 71,640 | — | $0 | 71,640 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-02-01 | 2020-02-04 | 9,750 | — | $0 | 39,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-02-01 | 2020-02-04 | 11,250 | — | $0 | 67,500 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-02-01 | 2020-02-04 | 12,063 | — | $0 | 24,125 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2020-02-01 | 2020-02-04 | 14,169 | $65.26 | $924.7K | 1,081,457 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2020-02-01 | 2020-02-04 | 33,063 | — | $0 | 1,095,626 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2020-01-31 | 2020-02-04 | 579 | $36.68 | $21.2K | 1,062,563 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-01-22 | 2020-01-23 | 1,031 | $82.45 | $85.0K | 1,061,984 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-01-22 | 2020-01-23 | 6,819 | $81.01 | $552.4K | 1,095,165 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-01-22 | 2020-01-23 | 32,150 | $81.85 | $2.63M | 1,063,015 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-01-21 | 2020-01-23 | 10,166 | $82.78 | $841.5K | 1,102,507 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-01-21 | 2020-01-23 | 29,311 | $81.98 | $2.40M | 1,112,673 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-01-21 | 2020-01-23 | 523 | $83.56 | $43.7K | 1,101,984 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-12-13 | 2019-12-17 | 87,500 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2019-12-13 | 2019-12-17 | 87,500 | — | $0 | 1,185,367 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2019-12-13 | 2019-12-17 | 43,383 | $76.88 | $3.34M | 1,141,984 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2019-12-06 | 2019-12-09 | 3,716 | $76.15 | $283.0K | 1,097,867 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2019-12-06 | 2019-12-09 | 23,152 | $77.72 | $1.80M | 1,101,583 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2019-12-06 | 2019-12-09 | 6,800 | $76.78 | $522.1K | 1,124,735 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2019-12-06 | 2019-12-09 | 6,332 | $75.73 | $479.5K | 1,131,535 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2019-12-05 | 2019-12-09 | 6,750 | $75.39 | $508.9K | 1,137,867 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2019-12-05 | 2019-12-09 | 11,287 | $74.62 | $842.2K | 1,166,580 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2019-12-05 | 2019-12-09 | 8,525 | $74.66 | $636.5K | 1,144,617 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2019-12-05 | 2019-12-09 | 996 | $74.08 | $73.8K | 1,153,142 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2019-12-05 | 2019-12-09 | 12,442 | $75.35 | $937.5K | 1,154,138 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2019-09-18 | 2019-10-02 | 14,812 | — | $0 | 14,812 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2019-09-18 | 2019-10-02 | 8,294 | — | $0 | 8,294 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-08-01 | 2019-08-05 | 11,250 | — | $0 | 78,750 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-08-01 | 2019-08-05 | 12,062 | — | $0 | 36,188 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-08-01 | 2019-08-05 | 9,750 | — | $0 | 48,750 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2019-08-01 | 2019-08-05 | 16,394 | $54.25 | $889.4K | 1,177,867 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2019-08-01 | 2019-08-05 | 33,062 | — | $0 | 1,194,261 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award deriv | 2019-06-27 | 2019-07-01 | 19,473 | — | $0 | 19,473 | SEC↗ |
| FOLD AMICUS THERAPEUTICS, INC. | A Award | 2019-06-27 | 2019-07-01 | 6,250 | — | $0 | 125,145 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-04-08 | 2019-04-10 | 35,000 | — | $0 | 87,500 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2019-04-08 | 2019-04-10 | 35,000 | — | $0 | 1,178,553 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2019-04-08 | 2019-04-10 | 17,354 | $58.51 | $1.02M | 1,161,199 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2019-02-01 | 2019-02-05 | 90,000 | — | $0 | 90,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2019-02-01 | 2019-02-05 | 145,000 | — | $0 | 145,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-02-01 | 2019-02-05 | 12,063 | — | $0 | 48,250 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2019-02-01 | 2019-02-05 | 9,750 | — | $0 | 58,500 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2019-02-01 | 2019-02-05 | 7,814 | $48.44 | $378.5K | 1,142,974 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2019-02-01 | 2019-02-05 | 21,813 | — | $0 | 1,150,788 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2019-01-31 | 2019-04-10 | 579 | $36.68 | $21.2K | 1,143,553 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-08-01 | 2018-08-03 | 12,062 | — | $0 | 60,313 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-08-01 | 2018-08-03 | 9,750 | — | $0 | 68,250 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-08-01 | 2018-08-03 | 21,812 | — | $0 | 1,139,791 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-08-01 | 2018-08-03 | 10,816 | $43.15 | $466.7K | 1,128,975 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-07-16 | 2018-07-17 | 12,194 | — | $0 | 132,806 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-07-16 | 2018-07-17 | 12,194 | $16.40 | $200.0K | 1,117,979 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2018-06-07 | 2018-06-11 | 8,912 | — | $0 | 8,912 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award | 2018-06-07 | 2018-06-11 | 3,081 | — | $0 | 8,895 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 13,927 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | U Tender | 2018-03-09 | 2018-03-13 | 37,394 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-02-14 | 2018-02-16 | 35,000 | — | $0 | 122,500 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-02-14 | 2018-02-16 | 17,353 | $62.30 | $1.08M | 1,105,785 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-02-14 | 2018-02-16 | 35,000 | — | $0 | 1,123,138 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2018-02-01 | 2018-02-02 | 78,000 | — | $0 | 78,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2018-02-01 | 2018-02-02 | 122,000 | — | $0 | 122,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-02-01 | 2018-02-02 | 12,063 | — | $0 | 72,375 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-02-01 | 2018-02-02 | 12,063 | — | $0 | 1,093,123 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-02-01 | 2018-02-02 | 5,981 | $59.60 | $356.5K | 1,087,142 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-01-31 | 2018-02-02 | 35,000 | — | $0 | 157,500 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-01-31 | 2018-02-02 | 35,000 | — | $0 | 1,098,413 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-01-31 | 2018-02-02 | 17,353 | $57.90 | $1.00M | 1,081,060 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-01-24 | 2018-01-26 | 35,000 | — | $0 | 192,500 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-01-24 | 2018-01-26 | 17,354 | $58.15 | $1.01M | 1,063,413 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-01-24 | 2018-01-26 | 35,000 | — | $0 | 1,080,767 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-01-16 | 2018-01-18 | 35,000 | — | $0 | 227,500 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-01-16 | 2018-01-18 | 17,083 | $52.10 | $890.0K | 1,045,767 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-01-16 | 2018-01-18 | 35,000 | — | $0 | 1,062,850 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise deriv | 2017-09-24 | 2017-09-26 | 2,375 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | F Tax w/h | 2017-09-24 | 2017-09-26 | 594 | $3.94 | $2.3K | 37,394 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise | 2017-09-24 | 2017-09-26 | 2,375 | — | $0 | 37,988 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2017-08-11 | 2017-08-14 | 262,500 | — | $0 | 262,500 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer | 2017-08-11 | 2017-08-14 | 124,106 | $3.40 | $422.0K | 1,027,850 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-08-01 | 2017-08-03 | 12,062 | — | $0 | 84,438 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-08-01 | 2017-08-03 | 12,062 | — | $0 | 1,156,489 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2017-08-01 | 2017-08-03 | 4,533 | $25.10 | $113.8K | 1,151,956 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise deriv | 2017-06-24 | 2017-06-27 | 9,058 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | F Tax w/h | 2017-06-24 | 2017-06-27 | 2,265 | $3.78 | $8.6K | 35,613 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise | 2017-06-24 | 2017-06-27 | 9,058 | — | $0 | 37,878 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2017-06-13 | 2017-06-15 | 16,236 | — | $0 | 16,236 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award | 2017-06-13 | 2017-06-15 | 5,814 | — | $0 | 5,814 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award | 2017-06-13 | 2017-06-16 | 5,814 | — | $0 | 147,814 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise deriv | 2017-06-12 | 2017-06-13 | 2,148 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise | 2017-06-12 | 2017-06-13 | 2,148 | — | $0 | 29,357 | SEC↗ |
| CASC Cascadian Therapeutics, In | F Tax w/h | 2017-06-12 | 2017-06-13 | 537 | $3.34 | $1.8K | 28,820 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2017-06-09 | 2017-06-13 | 13,927 | — | $0 | 13,927 | SEC↗ |
| CASC Cascadian Therapeutics, In | P Buy | 2017-02-02 | 2017-02-03 | 23,000 | $4.24 | $97.5K | 27,209 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2017-01-17 | 2017-01-19 | 145,000 | — | $0 | 145,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2017-01-17 | 2017-01-19 | 96,500 | — | $0 | 96,500 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer | 2016-07-01 | 2022-01-06 | 24,821 | $3.40 | $84.4K | 1,117,815 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer | 2016-07-01 | 2016-12-16 | 24,821 | $3.40 | $84.4K | 1,139,815 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2016-06-24 | 2016-06-28 | 54,347 | — | $0 | 54,347 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2016-06-09 | 2016-06-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2016-02-01 | 2016-02-03 | 1,925 | $16.09 | $31.0K | 1,142,636 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2015-09-24 | 2015-09-28 | 14,245 | — | $0 | 14,245 | SEC↗ |
| ONTY Oncothyreon Inc. | M Exercise deriv | 2015-09-05 | 2015-09-09 | 17,341 | — | $0 | 0 | SEC↗ |
| ONTY Oncothyreon Inc. | F Tax w/h | 2015-09-05 | 2015-09-09 | 4,336 | $3.25 | $14.1K | 13,005 | SEC↗ |
| ONTY Oncothyreon Inc. | M Exercise | 2015-09-05 | 2015-09-09 | 17,341 | — | $0 | 17,341 | SEC↗ |
| GBT Global Blood Therapeutics, | P Buy | 2015-08-17 | 2016-01-07 | 2,500 | $20.00 | $50.0K | 2,500 | SEC↗ |
| GBT Global Blood Therapeutics, | P Buy | 2015-08-17 | 2016-01-07 | 5,000 | $20.00 | $100.0K | 1,140,711 | SEC↗ |
| GBT Global Blood Therapeutics, | P Buy | 2015-08-17 | 2016-01-07 | 2,500 | $20.00 | $50.0K | 2,500 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-07-10 | 2015-07-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2015-06-12 | 2015-06-16 | 12,886 | — | $0 | 12,886 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2015-06-10 | 2015-06-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award | 2014-11-25 | 2014-12-15 | 32,000 | $7.83 | $250.6K | 142,000 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2014-06-18 | 2014-06-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2014-06-12 | 2014-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2014-06-06 | 2014-06-10 | 16,339 | — | $0 | 16,339 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award | 2014-03-12 | 2014-03-12 | 110,000 | $2.21 | $243.1K | 110,000 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 34,500 | $28.88 | $996.4K | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 34,500 | $10.07 | $347.4K | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 34,500 | $25.27 | $871.8K | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 32,500 | $25.27 | $821.3K | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 34,500 | $26.68 | $920.5K | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 32,000 | $28.67 | $917.4K | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 35,000 | $26.76 | $936.6K | 0 | SEC↗ |
| SNTS SANTARUS INC | U Tender | 2014-01-02 | 2014-01-06 | 335,500 | $32.00 | $10.74M | 0 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2013-09-05 | 2013-09-06 | 17,341 | — | $0 | 17,341 | SEC↗ |
| MSTX Mast Therapeutics, Inc. | A Award deriv | 2013-06-19 | 2013-06-21 | 62,451 | — | $0 | 62,451 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2013-06-13 | 2013-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SNTS SANTARUS INC | A Award deriv | 2013-06-11 | 2013-06-12 | 34,500 | — | $0 | 34,500 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2013-04-30 | 2013-05-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SNTS SANTARUS INC | P Buy | 2012-12-18 | 2012-12-19 | 185,000 | $10.88 | $2.01M | 335,500 | SEC↗ |
| ANX ADVENTRX PHARMACEUTICALS I | A Award deriv | 2012-09-05 | 2012-09-07 | 18,895 | — | $0 | 18,895 | SEC↗ |
| ANX ADVENTRX PHARMACEUTICALS I | A Award deriv | 2012-09-05 | 2012-09-07 | 14,171 | — | $0 | 14,171 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2012-07-25 | 2012-07-27 | 5,241 | $73.97 | $387.7K | 77,756 | SEC↗ |
| SNTS SANTARUS INC | A Award deriv | 2012-06-13 | 2012-06-14 | 34,500 | — | $0 | 34,500 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2012-06-13 | 2012-06-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AFFY AFFYMAX INC | A Award deriv | 2012-06-13 | 2012-06-18 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer | 2012-04-02 | 2012-04-03 | 757 | $36.58 | $27.7K | 82,997 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award deriv | 2012-03-30 | 2012-04-03 | 49,700 | — | $0 | 49,700 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award | 2012-03-30 | 2012-04-03 | 9,800 | — | $0 | 66,604 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award | 2012-03-30 | 2012-04-03 | 17,150 | — | $0 | 83,754 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2012-03-09 | 2012-03-12 | 34,500 | — | $0 | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2012-03-09 | 2012-03-12 | 15,000 | — | $0 | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2012-03-09 | 2012-03-12 | 34,500 | — | $0 | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2012-03-09 | 2012-03-12 | 32,000 | — | $0 | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2012-03-09 | 2012-03-12 | 34,500 | — | $0 | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2012-03-09 | 2012-03-12 | 34,500 | $2.47 | $85.2K | 150,500 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2012-03-09 | 2012-03-12 | 34,500 | $2.38 | $82.1K | 116,000 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2012-03-09 | 2012-03-12 | 32,000 | $1.18 | $37.8K | 81,500 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2012-03-09 | 2012-03-12 | 34,500 | $2.02 | $69.7K | 49,500 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2012-03-09 | 2012-03-12 | 15,000 | $3.00 | $45.0K | 15,000 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | F Tax w/h | 2012-02-01 | 2012-02-03 | 2,098 | $41.98 | $88.1K | 56,804 | SEC↗ |